‘Checkpoint inhibitor' drugs can slow skin and lung cancer
Drugs that block cancer cells from deactivating the body's immune response can extend life in people with terminal lung cancer and melanoma
Source: New Scientist - Drugs and Alcohol - Category: Drugs & Pharmacology Source Type: research
More News: Alcoholism | Cancer | Cancer & Oncology | Drugs & Pharmacology | Lung Cancer | Melanoma | Skin | Skin Cancer